Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/19196
Title: Predictors of Mortality in Dementia: The PRIME Study.
Austin Authors: Connors, Michael H;Ames, David;Boundy, Karyn;Clarnette, Roger;Kurrle, Sue;Mander, Alastair;Ward, John;Woodward, Michael M ;Brodaty, Henry
Affiliation: School of Medicine and Pharmacology, University of Western Australia, Australia, Perth, Australia
Dementia Collaborative Research Centre, School of Psychiatry, UNSW Australia, Sydney, Australia
Centre for Healthy Brain Ageing, School of Psychiatry, University of New South Wales, Sydney, Australia
National Ageing Research Institute, Melbourne, Australia
Queen Elizabeth Hospital, Adelaide, Australia
Sydney Medical School, University of Sydney, Sydney, Australia
Faculty of Health, Deakin University, Geelong, Australia
School of Medicine and Population Health, University of Newcastle, Newcastle, Australia
Medical and Cognitive Research Unit, Austin Health, Heidelberg, Victoria, Australia
University of Melbourne Academic Unit for Psychiatry of Old Age, Melbourne, Australia
Issue Date: 12-Apr-2016
Publication information: Journal of Alzheimer's disease : JAD 2016; 52(3): 967-74
Abstract: Dementia is a terminal illness. While various baseline characteristics of patients, such as age, sex, and dementia severity, are known to predict mortality, little research has examined how changes in patients' symptoms over time predict survival. There are also limited data on patients seen in memory clinics, as opposed to other health care settings, and whether antipsychotic medications are associated with mortality in dementia once patients' demographic and clinical features are controlled for. To identify predictors of mortality in patients with dementia. Of 970 patients recruited from nine memory clinics around Australia, 779 patients had dementia at baseline. Patients completed measures of dementia severity, cognition, functional ability, neuropsychiatric symptoms, caregiver burden, and medication use at baseline and at regular intervals over a three-year period. Mortality data were obtained from state registries eight years after baseline. Overall, 447 (57.4%) of the patients with dementia died within the eight years. Older age, male sex, more severe dementia and functional impairment at baseline, greater decline in dementia severity and functional impairment over six months, taking a larger number of medications, and use of atypical antipsychotic medication predicted earlier mortality. The findings confirm that demographic and diagnostic features predict the survival of patients with dementia. Importantly, the findings indicate that changes in dementia severity and functional impairment over time predict mortality independently of baseline levels, and provide further evidence for the higher mortality risk of patients taking antipsychotic medications.
URI: http://ahro.austin.org.au/austinjspui/handle/1/19196
DOI: 10.3233/JAD-150946
PubMed URL: 27079702
Type: Journal Article
Subjects: Death
dementia
longitudinal study
mortality
predictors
Appears in Collections:Journal articles

Show full item record

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.